Average Co-Inventor Count = 5.47
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (30 from 3,685 patents)
2. Rigel Pharmaceuticals, Incorporated (4 from 488 patents)
3. Other (1 from 832,880 patents)
4. Bristol Meyers Squibb Company (1 from 41 patents)
32 patents:
1. 12454531 - Substituted piperazine derivatives useful as T cell activators
2. 11964973 - Substituted bicyclic compounds useful as T cell activators
3. 11866430 - Naphthyridinone compounds useful as T cell activators
4. 11713316 - Substituted naphthyridinone compounds useful as T cell activators
5. 11584747 - Substituted pyridopyrimidinonyl compounds useful as T cell activators
6. 11352360 - TGF-beta inhibitors
7. 10961239 - TGF beta receptor antagonists
8. 10954238 - Substituted naphthyridinone compounds useful as T cell activators
9. 10669272 - Substituted naphthyridinone compounds useful as T cell activators
10. 10287295 - TGF-β inhibitors
11. 9981944 - GDF-8 inhibitors
12. 9956220 - Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors
13. 9884868 - TGF-beta inhibitors
14. 9598423 - Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
15. 9556179 - Substituted imidazoles as casein kinase 1 D/E inhibitors